Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes
暂无分享,去创建一个
[1] V. Nosé,et al. Case 32-2021: A 14-Year-Old Girl with Swelling of the Jaw and Hypercalcemia. , 2021, The New England journal of medicine.
[2] D. Dias-Santagata,et al. Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis , 2021, Endocrine Pathology.
[3] W. Young,et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers , 2021, Nature Reviews Endocrinology.
[4] D. Boehringer,et al. Genotype–phenotype correlation in von Hippel‐Lindau disease , 2021, Acta ophthalmologica.
[5] R. Robinson. Basal Cell Adenoma and Basal Cell Adenocarcinoma. , 2021, Surgical pathology clinics.
[6] J. Zedenius,et al. Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin , 2020, Endocrine Pathology.
[7] L. Sholl,et al. Biallelic PTCH1 Inactivation Is a Dominant Genomic Change in Sporadic Keratocystic Odontogenic Tumors , 2019, The American journal of surgical pathology.
[8] Feng Chen,et al. PTCH1 alterations are frequent but other genetic alterations are rare in sporadic odontogenic keratocysts. , 2019, Oral diseases.
[9] M. Sibony,et al. Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma—a retrospective and prospective study , 2019, Modern Pathology.
[10] Misty D Ruppert,et al. Ocular Manifestations of von Hippel-Lindau Disease , 2019, Cureus.
[11] S. Greenberg,et al. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. , 2019, JAMA otolaryngology-- head & neck surgery.
[12] S. Afshar,et al. What is the Prevalence of Undiagnosed Nevoid Basal Cell Carcinoma Syndrome in Children With an Odontogenic Keratocyst? , 2019, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[13] Mark Kriegsmann,et al. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56 , 2018, Applied immunohistochemistry & molecular morphology : AIMM.
[14] K. Magliocca,et al. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients , 2018, Head and Neck Pathology.
[15] A. Hebert,et al. The cutaneous manifestations of tuberous sclerosis complex , 2018, American journal of medical genetics. Part C, Seminars in medical genetics.
[16] I. Fonseca,et al. Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression , 2018, Modern Pathology.
[17] C. Bradford,et al. Head and neck paragangliomas: A two‐decade institutional experience and algorithm for management , 2017, Laryngoscope investigative otolaryngology.
[18] J. Kiilgaard,et al. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease , 2017, British Journal of Ophthalmology.
[19] W. Foulkes,et al. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome , 2017, Clinical Cancer Research.
[20] Dmitriy Sonkin,et al. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data , 2016, Human mutation.
[21] N. Matsubara,et al. Risk Factors for the Development of Desmoid Tumor After Colectomy in Patients with Familial Adenomatous Polyposis: Multicenter Retrospective Cohort Study in Japan , 2016, Annals of Surgical Oncology.
[22] S. Richard,et al. Characterization of endolymphatic sac tumors and von Hippel–Lindau disease in the International Endolymphatic Sac Tumor Registry , 2016, Head & neck.
[23] V. Nosé. Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect—PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome , 2016, Head and Neck Pathology.
[24] S. Granter,et al. Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome) , 2016, Head and Neck Pathology.
[25] C. Megerian,et al. Endolymphatic sac tumors. , 2015, Otolaryngologic clinics of North America.
[26] E. Swisher,et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. , 2013, Journal of the National Cancer Institute.
[27] A. Vortmeyer,et al. Nervous system involvement in von Hippel–Lindau disease: pathology and mechanisms , 2013, Acta Neuropathologica.
[28] N. Ngo,et al. Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations , 2012, British Journal of Cancer.
[29] M. Wagenmann,et al. Squamous Cell Carcinomas of the Head and Neck in Fanconi Anemia: Risk, Prevention, Therapy, and the Need for Guidelines , 2012, Klinische Pädiatrie.
[30] A. Bree,et al. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS) , 2011, American journal of medical genetics. Part A.
[31] K. Nah. Osteomas of the craniofacial region , 2011, Imaging science in dentistry.
[32] G. Fuller,et al. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. , 2011, Annals of diagnostic pathology.
[33] J. Tille,et al. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. , 2011, Thyroid : official journal of the American Thyroid Association.
[34] T-J. Li,et al. The Odontogenic Keratocyst , 2011, Journal of dental research.
[35] A. Horii,et al. Familial Cervical Paragangliomas with Lymph Node Metastasis Expressing Somatostatin Receptor Type 2A , 2010, Endocrine pathology.
[36] S. Richard,et al. Endolymphatic Sac Tumors in von Hippel-Lindau Disease: Report of Three Cases , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[37] P. Tran Ba Huy,et al. Isolate vertigo crisis revealing an endolymphatic sac tumor. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[38] S. Min,et al. A case report of Gardner syndrome with hereditary widespread osteomatous jaw lesions. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[39] M. Michal,et al. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene. , 2008, Pathology, research and practice.
[40] L. Michaels. Origin of Endolymphatic Sac Tumor , 2007, Head and neck pathology.
[41] M. Bisceglia,et al. Endolymphatic sac papillary tumor (Heffner tumor). , 2006, Advances in anatomic pathology.
[42] E. Oldfield,et al. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. , 2003, Journal of neurosurgery.
[43] N. Thakker,et al. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. , 2001, Oral oncology.
[44] I. Sugano,et al. Carcinoma in basal cell adenoma of the parotid gland. , 1997, Pathology, research and practice.
[45] J. Batsakis,et al. Tumors of the middle ear and endolymphatic sac. , 1994, Pathology annual.
[46] D. Evans,et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. , 1993, Journal of medical genetics.
[47] D. Heffner. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. , 1989, Cancer.
[48] R. Gorlin,et al. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. , 1960, The New England journal of medicine.
[49] J. Howell,et al. The basal-cell nevus: its relationship to multiple cutaneous cancers and associated anomalies of development. , 1959, A.M.A. archives of dermatology.